Compare Jaya Real Property Tbk. (JRPT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jaya Real Property Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Jaya Real Property Tbk. trades at Rp1,080 (market cap 13.94T, 2.6M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Jaya Real Property Tbk. is the larger of the two by market cap, and Jaya Real Property Tbk. is more actively traded (2.6M versus 1.77M). Which is the better fit depends on your goals.
| JRPT | TSPC | |
|---|---|---|
Market Cap | 13.94T | 11.36T |
Volume | 2.6M | 1.77M |
Lot | 26.04K | 17.71K |
Turnover | 2.81B | 4.61B |
Average Price | 1,079.74 | 2,603.9 |
Value | 2.81B | 4.61B |
Indicative Equilibrium Price | 1,080 | 2,590 |
Indicative Equilibrium Volume | 24.02K | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jaya Real Property Tbk.
PT Jaya Real Property Tbk (the Company) was established under Domestic Investment Law on May 25, 1979, based on the notarial deed No. 36 of Hobropoerwanto, S.H., at that time a notary in Jakarta, and amended with notarial deed No. 14 of the same notary as of December 6, 1979.. Jaya Real Property is the largest property company (in terms of market capitalization) listed on the JSX. It is a wholly owned subsidiary of PT Pembangunan Jaya (the Jaya Group), which is the oldest established property developer.
Read more on JRPT →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
